![Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling](https://mma.prnewswire.com/media/830740/Caris_Life_Sciences_Logo.jpg?w=200)
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
![Introducing PIONEER: a project to harness big data in prostate cancer research | Nature Reviews Urology Introducing PIONEER: a project to harness big data in prostate cancer research | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-020-0324-x/MediaObjects/41585_2020_324_Fig1_HTML.png)
Introducing PIONEER: a project to harness big data in prostate cancer research | Nature Reviews Urology
![ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study](https://www.urotoday.com/images/Rathkopf_Study_Schema.png)
ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study
![Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling](https://mma.prnewswire.com/media/1831219/Sorrento.jpg?p=facebook)
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
![PDF) Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium | Mitchell Gross - Academia.edu PDF) Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium | Mitchell Gross - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40044291/mini_magick20190222-21895-exx168.png?1550823876)
PDF) Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium | Mitchell Gross - Academia.edu
![Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling](https://1382778335.rsc.cdn77.org/wp-content/uploads/2022/06/Caris-Life-Sciences-Prostate-Cancer-Clinical-Trial-Consortium-and-Sorrento-Therapeutics-Announce-Collaboration-to-Advance-Precision-Medicine-Development-Using-Comprehensive-Genomic-Profiling.jpg)
Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
![Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News](https://www.karmanos.org/Uploads/Public/Images/Karmanos/News/heath-elizabeth.jpg)
Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium | Karmanos News
![Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN) - European Urology Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN) - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a12b4ac3-e9ef-47a6-b979-ce0b0bb52f49/gr1_lrg.jpg)
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN) - European Urology
![Prostate Cancer Clinical Trial Consortium (PCCTC) and Sorrento Therapeutics, Inc : r/BANDOFBROTHERSOFSRNE Prostate Cancer Clinical Trial Consortium (PCCTC) and Sorrento Therapeutics, Inc : r/BANDOFBROTHERSOFSRNE](https://external-preview.redd.it/CVAu4L0jR8Ve14YD6MoqvSj2ec1RxKSn7TXHzw6Bqg0.jpg?width=640&crop=smart&auto=webp&s=5e6db1f8e63b031c68c2df1a3e13055affa93eef)